Impilo is a Nordic investment company specializing in the healthcare sector, focusing on pharmaceuticals, medtech, and related services. With a commitment to sustainable development, Impilo actively invests in companies that contribute to healthier societies, leveraging its portfolio to foster long-term growth and positive health impacts.
- Biotech
- Pharmaceuticals
- Manufacturing
- Storage Solutions
- Sustainable Practices
Leadership
| Name | Title | ||
|---|---|---|---|
| Carolina Oscarius Dahl | Partner |
in/carolina-oscarius-dahl-9258a812
|
|
| Partner |
|
|
|
| Partner |
|
|
|
| Partner |
|
|
|
| Partner |
|
|
|
| Partner |
|
|
|
| Partner |
|
|
|
| Partner | COO |
|
|
|
| Investment Manager |
|
|
|
| Partner | CFO |
|
|
|
| Investment Director |
|
|
|
| Investment Director |
|
|
|
| Investment Director |
|
|
|
| Investment Manager |
|
|
|
| Investment Manager |
|
|
|
| Partner | CFO |
|
|
|
| Investment Manager |
|
|
|
| Director of Finance |
|
|
Recent Transactions involving Impilo
| Deal | Target | Platform | Buyer | Industry |
|---|---|---|---|---|
KKR and Impilo announce strategic partnership together with management in rare disease platform Immedica Pharma |
Immedica Pharma |
ImpiloKKR |
Pharmaceuticals | |
|
|
|
|
|
|
|
|
|
|
The Lower and Middle Market M&A Platform
See how PrivSource can help you close more deals.
Learn more →